Bold Debates on the Future of Thrombectomy in Stroke: ESOC 2025
European Stroke Organisation (ESO) shared an insightful post on X:
”Couldn’t attend live? Explore one of the key discussions from Day 2 at ESOC 2025 in Helsinki. Our guests debate large core trial results: Are questions still open? Should thrombectomy be for all?”
Watch the key discussions here.
At ESOC 2025 in Helsinki, one of the key discussions on Day 2 centered on the evolving evidence from large core stroke trials.
Experts Anne Hege Nymoen Aamodt and Götz Thomalla debated whether current results fully address the complexities of patient selection and whether thrombectomy should be expanded to all patients.
The session highlighted ongoing uncertainties and the need for further research to refine treatment strategies in this challenging stroke population.
Do not miss the latest updates on global discussions, stay tuned with Hemostasis Today.
-
Apr 8, 2026, 16:25Xiaoying Chen: Teleneurological Ward As A Practical Way to Support High-Quality Stroke Care Beyond Major Centres
-
Apr 8, 2026, 16:24Ney Carter Borges: Endocrine Drivers of Resistant Hypertension – Insights from the MOMENTUM Trial at ACC 26
-
Apr 8, 2026, 16:21Jonathan Gelber: Exploring Papaya Extract as an Option to Elevate Platelet Numbers Before PRP
-
Apr 8, 2026, 16:21Marilena Vrana: Take Our New Global Survey on Patient Experiences with Plasma-Derived Medicines
-
Apr 8, 2026, 16:19Jaideep Patel: Are We Underestimating Heart Disease Risk in South Asians?
-
Apr 8, 2026, 16:16Hans Middelhoven: HARMONICS – Improving Stroke Care Outcomes in Spain and Portugal
-
Apr 8, 2026, 16:16Tiffany Hall: HerCare – the Ultimate ‘BOGO’ in Maternal Health
-
Apr 8, 2026, 16:14Haroun Gajraj: UGFS as a Minimally Invasive and Safe Option for Superficial Venous Thrombosis
-
Apr 8, 2026, 16:13Lama Samia: Biochemical Cascade of Myocardial Infarction